10x Genomics
257 hedge funds and large institutions have $5.03B invested in 10x Genomics in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 85 increasing their positions, 81 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
5% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 81
3% less funds holding
Funds holding: 266 → 257 (-9)
15% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 47
Holders
257
Holding in Top 10
7
Calls
$30.7M
Puts
$10.9M
Top Buyers
| 1 | +$90.5M | |
| 2 | +$88.7M | |
| 3 | +$65.3M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$58.6M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$57.2M |
Top Sellers
| 1 | -$55.2M | |
| 2 | -$39.8M | |
| 3 | -$36.3M | |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$34.2M |
| 5 |
Man Group
London,
United Kingdom
|
-$19.8M |